Please use this identifier to cite or link to this item:
https://scholarbank.nus.edu.sg/handle/10635/229246
DC Field | Value | |
---|---|---|
dc.title | Conversion from twice-daily prograf to once-daily advagraf in multi-ethnic asian adult renal transplant recipients with or without concomitant use of diltiazem - impact of CYP3A5 genetic polymorphism on tacrolimus pharmacokinetics | |
dc.contributor.author | Yau, Wai-Ping | |
dc.contributor.author | Vathsala, Anantharaman | |
dc.date.accessioned | 2022-07-27T02:19:55Z | |
dc.date.available | 2022-07-27T02:19:55Z | |
dc.date.issued | 2016-07-01 | |
dc.identifier.citation | Yau, Wai-Ping, Vathsala, Anantharaman (2016-07-01). Conversion from twice-daily prograf to once-daily advagraf in multi-ethnic asian adult renal transplant recipients with or without concomitant use of diltiazem - impact of CYP3A5 genetic polymorphism on tacrolimus pharmacokinetics 100 (7) : S714-S714. ScholarBank@NUS Repository. | |
dc.identifier.issn | 00411337 | |
dc.identifier.issn | 15346080 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/229246 | |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | |
dc.source | Elements | |
dc.subject | Science & Technology | |
dc.subject | Life Sciences & Biomedicine | |
dc.subject | Immunology | |
dc.subject | Surgery | |
dc.subject | Transplantation | |
dc.type | Conference Paper | |
dc.date.updated | 2022-07-22T15:12:27Z | |
dc.contributor.department | MEDICINE | |
dc.contributor.department | PHARMACY | |
dc.description.volume | 100 | |
dc.description.issue | 7 | |
dc.description.page | S714-S714 | |
dc.published.state | Published | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
Yau2018_Article_ConversionFromTwice-DailyProgr.pdf | 1.01 MB | Adobe PDF | CLOSED | Published |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.